Mammalian GABA shunt (glutamate to GABA to succinate)Metabolic Pathwaygaba_shunt
The mammalian GABA shunt is grounded to the human enzymes glutamate decarboxylase GAD1 (UniProtKB:Q99259, GO:0004351, EC 4.1.1.15), 4-aminobutyrate aminotransferase ABAT (P80404, GO:0034386, EC 2.6.1.19) and succinate-semialdehyde dehydrogenase ALDH5A1 (P51649, GO:0004777, EC 1.2.1.24). GO molecular-function terms were taken from the human GOA records; Reactome reaction ids and titles were verified against the local reactome cache. The GAD node uses a PANTHER family selector (PTHR45677) with both isoforms as representatives — GAD1/GAD67 (constitutive, cytosolic) and GAD2/GAD65 (synaptic-vesicle-associated); ABAT and ALDH5A1 use their own family selectors. The pathway is compartment-split: GABA synthesis (GAD) is cytosolic while GABA catabolism (ABAT, ALDH5A1) is in the mitochondrial matrix (GABA is transported in). Both GAD and ABAT are PLP-dependent; ABAT regenerates the glutamate consumed by GAD. The terminal succinate enters the TCA cycle, so the shunt bypasses the 2-oxoglutarate -> succinyl-CoA -> succinate segment. Disorders: GAD1 -> spastic paraplegia / cerebral palsy / DEE; ABAT -> GABA-transaminase deficiency; ALDH5A1 -> succinic semialdehyde dehydrogenase deficiency (GHB/4-hydroxybutyric aciduria). ABAT's secondary beta-amino-acid transaminase activity links to pyrimidine (thymine) catabolism. This concrete mammalian realization should not be broadened to cover the P. putida GabT/GabD pathway; bacterial GABA transport, regulation, and enzyme implementations belong in a separate bacterial module, with a future abstract GABA-shunt motif available to link the two realizations through `conforms_to`.
Connections
Part 1: GABA synthesis (glutamate decarboxylation)
L-glutamate to GABA + CO2Reactiongad_step
Annotons
GAD1/GAD2: glutamate decarboxylase
gad_activity
Participant: Family: Glutamate decarboxylase family (GAD1/GAD2)
Function
glutamate decarboxylase activityGO:0004351
Substrates:
L-glutamate
Products:
gamma-aminobutyric acid (GABA)
CO2
Locations
PLP-dependent decarboxylation of glutamate to the inhibitory neurotransmitter GABA. GAD1 (GAD67) is the constitutive cytosolic isoform; GAD2 (GAD65) is membrane-associated at synaptic vesicles. GAD1 deficiency -> spastic paraplegia / cerebral palsy / epileptic encephalopathy.
Part 2: GABA transamination (first catabolic step)
GABA + 2-oxoglutarate to succinate semialdehyde + L-glutamateReactionabat_step
Annotons
ABAT: 4-aminobutyrate aminotransferase (GABA-T)
abat_activity
Participant: Family: 4-aminobutyrate aminotransferase family (ABAT)
Function
4-aminobutyrate:2-oxoglutarate transaminase activityGO:0034386
Substrates:
gamma-aminobutyric acid (GABA)
2-oxoglutarate
Products:
succinate semialdehyde
L-glutamate
Locations
PLP-dependent mitochondrial GABA transaminase: transfers GABA's amino group to 2-oxoglutarate, yielding succinate semialdehyde and regenerating glutamate. First step of GABA degradation; deficiency = GABA-transaminase deficiency.
Part 3: oxidation to succinate (feeds TCA cycle)
succinate semialdehyde + NAD+ to succinate + NADHReactionaldh5a1_step
Annotons
ALDH5A1: succinate-semialdehyde dehydrogenase (SSADH)
aldh5a1_activity
Participant: Family: Succinate-semialdehyde dehydrogenase family (ALDH5A1)
Function
succinate-semialdehyde dehydrogenase (NAD+) activityGO:0004777
Substrates:
succinate semialdehyde
NAD+
Products:
succinate
NADH
Locations
NAD+-dependent oxidation of succinate semialdehyde to succinate, which enters the TCA cycle — completing the GABA shunt. Deficiency = SSADH deficiency (4-hydroxybutyric / GHB aciduria).